Navigation Links
ReSeeVit 3Z

ProductsReSeeVit 3Z
Company Veatch Ophthalmic Instruments
Item ReSeeVit 3Z
Features 
Description The ReSeeVit 3Z slit lamp is designed to for use with digital video imaging. This video ready slit lamp offers the popular horizontal style light source. It is another addition to the ReSeeVit family of slit lamps that offers the best products on the market to capture clear, crisp digital images in the most ergonomic design.
Info Veatch Ophthalmic Instruments
Customer Service: (800) 447-7511
Web site: http://www.veatchinstruments.com/

Related medicine products :

1. ReSeeVit 5V
2. ReSeeVit 5Z
3. ReSeeVit CR-DGi Digital Imaging Sys Cmp
4. ReSeeVit Slit Lamp System
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products:
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness Celebration ... Conference Center in Chesapeake, Virginia. Each year, ARDX celebrates ... in the Hampton Roads region. The 2015 Women’s History ... Women grow stronger through sharing their stories and learning the ... WWC™ theme is T-talk where we will share a cup ...
(Date:3/28/2015)... 2015 Servpro of Paso Robles ... released a report about the link between mold and ... and according to recent medical research, may even cause ... the Environmental Protection Agency, people with sensitivity to mold ... mold may trigger asthma attacks for asthma sufferers. The ...
(Date:3/27/2015)... Miami, FL (PRWEB) March 27, 2015 ... relationship guide from dating experts Samantha Sanderson and Jason ... a frenzied buzz of media attention. The commotion surrounding ... Sean Roman, prompting him to publish an in-depth review ... emotionally devastated when the men in their lives suddenly ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 In her mid-forties ... prevented her from working, Monica K. arrived at JET ... mending department quiet, defensive and scared. The owners and staff ... Support Services (EPSS) to offer jobs to challenged residents ... patience and a willingness to begin with the end in ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 The ... ) that allege the statin medication increases the risk ... granted Pfizer Inc.’s Motion to Dismiss four individual cases ... a Case Management Order issued in the U.S. District ... Court determined that the dismissals were warranted because the ...
Breaking Medicine News(10 mins):Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
... But sites devoted to complementary or alternative medicine may ... 11 (HealthDay News) -- Just 5 percent of Web ... pages focused on complementary or alternative medicine are 15 ... other false information, a new study says. , Moreover, ...
... DC When the public considers competing arguments about a ... agree with the expert whose values are closest to their ... will hold true for nanotechnology, a key study has found. ... today by the Project on Emerging Nanotechnologies (PEN). The study ...
... ... - $352 Average Patient Charge (APC) ... - $13.9 Million EBITDA From Continuing Operations ... 2008 Guidance, SCOTTSDALE, Ariz., Feb. 11 Rural/Metro,Corporation (Nasdaq: RURL ), a leading provider ...
... National Insurers Bring Programs to the State, While ... According to a New Report from HealthLeaders-InterStudy, ... of managed care market intelligence, reports that pay-for-,performance ... According to the,latest Arizona Health Plan Analysis, the ...
... recent years, increasing attention,has been paid to the ... In some instances, proponents of LBA made,overly-optimistic claims ... predictor in,the underwriting process. Milliman expert Jonathan Shreve, ... effective use of Lifestyle-Based,Analytics as an advance in ...
... SAN JUAN, Puerto Rico, Feb. 11 Triple-S,Management Corporation ... in,Puerto Rico, today announced record consolidated operating income of ... $2.15 for the year ended,December 31, 2007 (including $0.07 ... Company,s strong market position and medical cost,management., ...
Cached Medicine News:Health News:Most Breast Cancer Web Pages Contain Reliable Information 2Health News:Nanotechnology's future depends on who the public trusts 2Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 2Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 3Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 4Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 5Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 6Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 7Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 8Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 9Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 10Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 11Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 12Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 13Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 14Health News:Rural/Metro Announces Results for Fiscal 2008 Second Quarter 15Health News:Pay-For-Performance Not Getting a Red-Carpet Reception in Arizona 2Health News:Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection 2Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 2Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 3Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 4Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 5Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 6Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 7Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 8Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 9Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 10Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 11Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 12Health News:Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007 13
(Date:3/27/2015)... , March 27, 2015 Report ... for leading ophthalmic drug companies  What does ... pharma ophthalmic industry ? Visiongain,s brand new report shows ... and prospects there. Our 242-page report provides ... areas in the industry and the future market prospects. ...
(Date:3/27/2015)... 27, 2015 As of February, InControl ... devices for women. "Shipping thousands of ... part is the hundreds of letters, emails and ... have been positively impacted by our technology," said ... InControl recently released Apex, an over-the-counter solution ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5